Almirall, S.A. (BME:ALM)

Market Cap	2.37B
Revenue (ttm)	1.03B
Net Income (ttm)	24.35M
Shares Out	213.47M
EPS (ttm)	0.11
PE Ratio	97.50
Forward PE	36.02
Dividend	0.18 (1.63%)
Ex-Dividend Date	May 15, 2025

Volume	88,160
Average Volume	158,698
Open	11.26
Previous Close	11.28
Day's Range	11.12 - 11.32
52-Week Range	8.03 - 11.40
Beta	0.30
RSI	63.06
Earnings Date	May 12, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ALM